| CAS Number | 1415559-43-1 |
| Catalog Number | AG009CAD |
| Chemical Name | CDK9 inhibitor |
| IUPAC Name | N-[5-[[6-[3-(1,3-dioxoisoindol-2-yl)phenyl]pyrimidin-4-yl]amino]-2-methylphenyl]methanesulfonamide |
| InChI | InChI=1S/C26H21N5O4S/c1-16-10-11-18(13-22(16)30-36(2,34)35)29-24-14-23(27-15-28-24)17-6-5-7-19(12-17)31-25(32)20-8-3-4-9-21(20)26(31)33/h3-15,30H,1-2H3,(H,27,28,29) |
| InChI Key | CKUFOBCNTCLXJP-UHFFFAOYSA-N |
| MDL Number | MFCD22124471 |
| Molecular Formula | C26H21N5O4S |
| Molecular Weight | 499.541 |
| SMILES | CC1C=CC(NC2C=C(C3C=C(N4C(=O)C5C=CC=CC=5C4=O)C=CC=3)N=CN=2)=CC=1NS(=O)(=O)C |
| Synonyms | CDK9 inhibitor,
CDK9-IN-1,
1415559-43-1,
C26H21N5O4S,
CHEMBL3392878,
CHEBI:91444,
DTXSID40735344,
3532AH,
ZINC95641936,
AKOS030526501,
CS-0456,
NCGC00346946-01,
NCGC00346946-02,
HY-13231,
A3294,
W-5866,
N-[5-({6-[3-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)phenyl]pyrimidin-4-yl}amino)-2-methylphenyl]methanesulfonamide,
N-[5-[[6-[3-(1,3-dioxoisoindol-2-yl)phenyl]pyrimidin-4-yl]amino]-2-methylphenyl]methanesulfonamide,
|
| Complexity | 900 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 499.131g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 36 |
| Hydrogen Bond Acceptor Count | 8 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 499.545g/mol |
| Monoisotopic Mass | 499.131g/mol |
| Rotatable Bond Count | 6 |
| Topological Polar Surface Area | 130A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.6 |
GHS Hazard and Precautionary Statements
Certificate of Analysis
Lot Number